PRODUCT
Development
Technical
in vitro
development
(mosquitoes)
In vivo
Development
(humans)
Registration
Planned
release
We are exploring new applications based on the formation of glycoconjugates between a carbohydrate molecule (G) and other substances (R), such as: Agrochemicals Antiseptics Antivirals Others
PRODUCT
Development
Technical
in vitro
development
(mosquitoes)
In vivo
Development
(humans)
Registration
Planned
release
GS0032
For veterynary/Animal Health
2026-27
EU-USA
GS0010
Agriculture
2027-28
EU-USA
OTHERS
Sanitisation
PRODUCT
Technical
development
development
in vitro
(mosquitoes)
development
in vivo
(humans)
Registration
Planned
release
| Description |
Characteristic DEET |
Anticipated Formulation |
|---|---|---|
|
Natural, organic |
NO |
YES |
|
Irritating to the skin or eyes |
YES |
Not to skin. Potentially not to eyes |
|
Allergenic |
NO |
NO |
|
Duration of action |
6 h |
~24h |
|
Can be applied as a water-based spray |
NO |
YES |
|
Low Odour |
NO |
YES |
|
Washes off in water or on sweating |
NO |
NO |
|
Competitive cost |
N/A |
YES |
|
Damages clothing |
YES |
NO |
|
Environmentally friendly |
NO |
YES |
Glycoscience S.L.
Astondo Bidea, 612
BicBizkaia
48160 DERIO
BIZKAIA (Spain)
Project Glyco: development of long-lasting, low-toxicity natural insect repellent precursors. File no: ZL-2022/00110. Hazitek support programme for business R&D.
Co-financed by the Basque Government and the European Union through the European Regional Development Fund 2021-2027 (ERDF).
Glycoscience’s project Development of insect repellent glycoconjugates with very high efficiency and low toxicity, subsidised by the Centre for the Development of Industrial Technology (CDTI). Glycoscience has received a CDTI grant through the NEOTEC initiative.
INNOVATIVE SME
Valid until 14 May 2024